ArticleCardiovascular & hematological disorders drug targets2026
Study of Bone Marrow Findings in Human Immunodeficiency Virus (HIV) Positive Patients in a Tertiary Care Hospital.
Article in Cardiovascular & hematological disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHuman immunodeficiency virus (HIV) has emerged as a cause of morbidity and mortality worldwide. HIV positive patients commonly suffer from various hematological abnormalities of all lineages, which are diverse and can occur at any stage of infection. Hematologists should be aware of bone marrow changes associated with retroviral disease (RVD) so that appropriate and prompt treatment can be given to these patients.
methodsThe study was carried out in the department of clinical pathology of a tertiary care hospital for the duration of 1 year, from January 2023 to December 2023. Out of a total of 90 bone marrow received, 20 patients were retrospectively studied for morphological changes in bone marrow who were HIV positive on ELISA and confirmed on Western blot.
resultsThe age range of the study population was 22 to 60 years. There was a predominance of male participants (85%). The predominant hematological abnormality on peripheral smear was anemia (90%). Microcytic hypochromic type of anemia was the most frequently observed finding. The bone marrow was hypercellular (70%) in most cases. Erythroid hyperplasia was seen in 14 cases. Erythroid normoblastic maturation was predominant (70%). Dysplasia was noted in 12 cases out of 20 cases, with isolated erythroid dysplasia (25%) being the most common. Reactive changes associated with HIV were also observed. In addition, we also reported one case of autoimmune hemolytic anemia and another of visceral leishmaniasis, both associated with HIV infection.
conclusionA bone marrow study, along with a detailed approach to all relevant possible contributors and clinical history, should be considered for the diagnostic approach in documenting peripheral hematological abnormalities, opportunistic infections, and malignancies in HIV positive patients.
Indexed as
Identifiers
41235573What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.